Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil passes law for better access to medtech, subject to selection criteria

This article was originally published in Clinica

Executive Summary

Brazil has passed legislation that promises to guarantee greater access to medicines and medical technology through the national health system (SUS). However, this access will be subject to new safety, efficacy and cost-effectiveness criteria. Law 12.401, sanctioned by Brazilian president Dilma Rousseff on 29 April, sets out the basic criteria and standards that will apply to the scheme, and the system and procedures that will be used to determine health service needs and policy and technology options, and to implement the programme. It comes into force in six months.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097212

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel